ArticleCancer research2024

The USP1 Inhibitor KSQ-4279 Overcomes PARP Inhibitor Resistance in Homologous Recombination-Deficient Tumors.

Louise Cadzow et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.